Effect of Cilostazol Endothelial Progenitor Cells and Collateral Formation in Peripheral Occlusive Artery Disease (PAOD)

Condition:   Peripheral Arterial Diseases
Intervention:   Drug: Active comparator (cilostazol) and Placebo comparator
Sponsors:   National Cheng-Kung University Hospital;   National Cheng-Kung University Hospital;   Department of Health, Executive Yuan, R.O.C. (Taiwan)
Active, not recruiting – verified September 2013

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.